1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Eosinophilic Leukemia, Acute in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akutagawa, H; Mayumi, M; Mikawa, H; Morita, M; Nambu, M; Ohshima, Y; Uenoyama, Y | 1 |
| Aramaki, Y; Ichimori, Y; Masuya, H; Nishinaka, Y; Sugawara, T; Yoshida, H | 1 |
| Masuzawa, Y; Shikano, M; Yazawa, K | 1 |
| Shute, J | 1 |
| Mayumi, M; Mikawa, H; Mori, KJ; Morita, M; Tsuruta, S | 1 |
| Iwai, Y; Kim, KM; Lee, KC; Mayumi, M; Mikawa, H; Morita, M; Saito, H; Tanaka, M; Yodoi, J | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Eosinophilic Leukemia, Acute
| Article | Year |
|---|---|
Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.
Topics: Actins; Blood Proteins; Bucladesine; Calcimycin; Calcium-Transporting ATPases; Cell Differentiation; Culture Media; Dose-Response Relationship, Drug; Eosinophil Granule Proteins; Eosinophils; Humans; Hypersensitivity; Immunoglobulin G; Inflammation; Leukemia, Eosinophilic, Acute; Leukemia, T-Cell; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Phthalazines; Platelet Activating Factor; Polymers; Ribonucleases; Tumor Cells, Cultured | 1993 |
A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells.
Topics: Complement C5a; Humans; Imidazoles; Indicators and Reagents; Interferon-gamma; Kinetics; Leukemia, Eosinophilic, Acute; Luminescent Measurements; Luminol; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pyrazines; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1.
Topics: Acetyltransferases; Arachidonic Acid; Calcimycin; Docosahexaenoic Acids; Eosinophils; Fatty Acids, Nonesterified; Humans; Interferon-gamma; Leukemia, Eosinophilic, Acute; Phosphatidylcholines; Phosphatidylethanolamines; Platelet Activating Factor; Tumor Cells, Cultured | 1993 |
Signal transduction mechanisms in human eosinophils.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blood Proteins; Bucladesine; Calcium Signaling; Cell Differentiation; Cells, Cultured; Chemotaxis, Leukocyte; Cyclic AMP; Cytokines; Enzyme Inhibitors; Eosinophil Granule Proteins; Eosinophil Peroxidase; Eosinophil-Derived Neurotoxin; Eosinophils; Guinea Pigs; Humans; Hypereosinophilic Syndrome; Leukemia, Eosinophilic, Acute; Macaca mulatta; Peroxidases; Phosphorylation; Platelet Activating Factor; Protein Kinase C; Protein Processing, Post-Translational; Proteins; Receptors, Cytokine; Receptors, Fc; Ribonucleases; Signal Transduction; Tumor Cells, Cultured | 1993 |
Ketotifen inhibits PAF-induced actin polymerization in a human eosinophilic leukaemia cell line, EoL-1.
Topics: Actins; Cell Line; Chemotaxis; Eosinophils; Flow Cytometry; Humans; Ketotifen; Leukemia, Eosinophilic, Acute; Platelet Activating Factor; Polymers | 1990 |
Regulation of Fc epsilon receptor 2 (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937 by transforming growth factor beta.
Topics: Antigens, Differentiation, B-Lymphocyte; Cell Line, Transformed; Dexamethasone; Eosinophils; Humans; Interferon-gamma; Interleukin-4; Interleukins; Leukemia, Eosinophilic, Acute; Leukemia, Myeloid; Monocytes; Platelet Activating Factor; Receptors, Fc; Receptors, IgE; Transforming Growth Factors | 1989 |